Curtiss Wright (CW) On Cheswick Expansion And Earnings Momentum Still Looks Fully Valued
Curtiss-Wright (CW) is back in focus after announcing an $80 million multi-year expansion of its Cheswick, Pennsylvania facility, along with recent earnings estimate revisions that have supported a favorable Zacks Rank for the stock.
See our latest analysis for Curtiss-Wright.
The recent Cheswick expansion news lands as Curtiss-Wright’s share price sits at US$751.64, with short term momentum cooling slightly but longer term trends still strong, reflected in a 31.32% year to date share price return and a 56.26% 1 year total shareholder return.
If this kind of defense and critical infrastructure story interests you, it could be a good moment to broaden your watchlist and scan 90 nuclear energy infrastructure stocks.
After Curtiss-Wright’s strong run and fresh Cheswick investment, the stock still trades at an 8.4% discount to the average analyst target of US$814.83. Is this a genuine gap in expectations or the market pricing in risk?
Most Popular Narrative: 5% Undervalued
The most followed Curtiss-Wright narrative places fair value at about $791 per share, a touch above the latest close at $751.64, framing that analyst discount as modest rather than dramatic.
Record backlog growth (+12% YTD to $3.8b), strong book-to-bill ratios (1.2x in A&D), and a healthy order pipeline in both defense and nuclear align with management's confidence in posting 9–10% sales growth, 16–19% EPS growth, and over 100 bps of margin expansion in 2025, signaling undervaluation if current pricing underappreciates this forward visibility and operational leverage.
Want to understand why Curtiss-Wright is being treated more like a growth compounder than a mature contractor? The narrative leans on sustained revenue expansion, rising margins, and a richer future earnings multiple than many peers. Curious how those moving parts add up to that fair value band? The full story unpacks the growth, profitability, and valuation assumptions driving that $791 number.
Result: Fair Value of $791 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Curtiss-Wright’s story could change quickly if large defense or nuclear contracts are delayed, or if customers shift budgets toward software and away from its hardware focus.
Find out about the key risks to this Curtiss-Wright narrative.
Another View: Curtiss-Wright Looks Expensive On Earnings
The popular Curtiss-Wright narrative leans on a fair value of about $791, yet the current P/E of 54.3x tells a different story. That P/E is higher than the estimated fair ratio of 31x, the US Aerospace & Defense industry at 40.5x, and even close peers at 53.9x. This suggests investors are paying up for growth expectations that may not be exceptional. If earnings or sentiment cool, there may be limited room for the multiple to compress before it lines up with that fair ratio.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With mixed views on whether Curtiss-Wright looks undervalued or expensive today, it makes sense to act quickly, test the numbers yourself, and then weigh those findings against the 2 key rewards
Looking for more investment ideas beyond Curtiss-Wright?
If Curtiss-Wright has your attention, do not stop there. Use the Simply Wall St screener to uncover other stocks that could fit your portfolio goals.
- Target dependable cash generators by reviewing companies highlighted in the solid balance sheet and fundamentals stocks screener (48 results) and see which ones align with your risk comfort and return expectations.
- Hunt for potential bargains by scanning the 47 high quality undervalued stocks and compare how their valuations stack up against the assumptions you are using for Curtiss-Wright.
- Spot off-the-radar opportunities by checking the screener containing 20 high quality undiscovered gems so you are not late to stories other investors only notice after a big move.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com